Study objective: To determine the value of gadolinium-enhanced MRI in the assessment of disease activity in chronic infiltrative lung diseases (CILDs). Design: Retrospective study. Setting: University hospital. Materials and Methods: Twenty-five consecutive patients with CILD were studied. The following diseases were diagnosed: sarcoidosis (n ‫؍‬ 10), bronchiolitis obliterans organizing pneumonia (n ‫؍‬ 3), usual interstitial pneumonia (n ‫؍‬ 4), radiation pneumonia (n ‫؍‬ 2), desquamative interstitial pneumonia (n ‫؍‬ 1), rheumatoid lung (n ‫؍‬ 1), vasculitis (n ‫؍‬ 1), alveolar proteinosis (n ‫؍‬ 1), bronchioloalveolar carcinoma (n ‫؍‬ 1), and chronic eosinophilic pneumonia (n ‫؍‬ 1). In each patient, the disease activity was assessed by one or more of the following studies: BAL (n ‫؍‬ 18), gallium-radioisotope lung scanning (n ‫؍‬ 6), serum angiotensin-converting enzyme assay (n ‫؍‬ 10), and open lung biopsy (n ‫؍‬ 4). T1-weighted breath-hold MRI studies were obtained before and after IV injection of gadolinium. The MRI examinations were analyzed to assess the presence or absence of lesional enhancement.
C
hronic infiltrative lung disease (CILD) is common and has many recognized causes. 1, 2 Regardless of the origin, the disease usually progresses at varying rates from an inflammatory alveolitis to interstitial fibrosis. 3, 4 To effectively prevent this progression, high doses of corticosteroids can be given but are effective only in the early stage of disease. 5, 6 Once fibrosis has developed, no effective therapy is known. The lack of an objective system for assessment of CILD to evaluate disease course and effectiveness of therapy is a major problem. Galliumradioisotope lung scanning, high-resolution CT (HRCT), and BAL have been advocated as means of assessing activity and stage of disease 2, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] ; however, they are often insensitive or nonspecific. 2, 12 Open lung biopsy provides a direct evaluation of the histologic appearance of the lung, but it cannot be repeated for follow-up purposes. Some authors used unenhanced MRI to evaluate CILD. 17, 18 However, to our knowledge, there are no reports assessing the value of gadolinium-enhanced MRI to evaluate disease activity. Gadolinium enhancement might correlate with disease activity, because pulmonary insults inducing CILD disrupt capillary endothelium and permit the extravasation of gadolinium into the interstitial and alveolar spaces. 19 This is a retrospective, early report of gadolinium-enhanced MRI in comparison to disease activity as suggested by one or more nonradiologic techniques.
Materials and Methods

Patient Population
The study included 25 consecutive patients who had parenchymal opacification on CT scans and a definitive diagnosis made on the basis of findings at examinations of specimens obtained by means of open lung (n ϭ 8), transbronchial (n ϭ 12), or percutaneous needle biopsy (n ϭ 5). Our study group consisted of 16 men and 9 women, ages 35 to 67 years, with clinical symptoms or radiographic findings that were present for Ͼ 1 month (from 40 days to 3 years). In these 25 patients, 10 diseases were diagnosed: sarcoidosis (n ϭ 10), usual interstitial pneumonia (UIP; n ϭ 4), desquamative interstitial pneumonia (DIP; n ϭ 1), rheumatoid lung (n ϭ 1), bronchiolitis obliterans organizing pneumonia (BOOP; n ϭ 3), radiation pneumonia (n ϭ 2), bronchioloalveolar carcinoma (n ϭ 1), chronic eosinophilic pneumonia (n ϭ 1), alveolar proteinosis (n ϭ 1), and vasculitis (n ϭ 1).
Imaging Techniques
All patients had MRI and CT examinations. MRI examinations were performed with a 1.5 -T system (Magnetom Vision; Siemens, Enlargen, Germany). All patients were imaged in the transverse plane. In each patient, spoiled gradient-echo T1-weighted images were obtained during full inspiration with the following parameters: repetition time, 168 ms; echo time, 4.8 ms; flip angle, 75°; pixel size, 2.15 mm ϫ 1.56 mm; slice thickness, 5 mm; scan time, 15 s with anteroposterior phase encoding. The chosen slice thickness was the thinner one available with this sequence. After a precontrast MRI study was obtained, a bolus of gadolinium, 0.1 mmol/kg of body weight, was injected through an antecubital vein on the forearm. A first set of enhanced T1-weighted MRI studies was obtained 60 s after the end of the gadolinium injection, and then identical sets of contrast-enhanced images were obtained at every 60 s up to 3 min. Artifacts due to cardiac pulsations were visible in all examinations. Physiologic motions, which include cardiac pulsations, are the most frequent causes of artifacts encountered in MRI of the thorax. Motion causes ghost images to occur in the phase encoding direction. CT Abnormality MRI EnhancementAbnormality
*SAR ϭ sarcoidosis; RHL ϭ rheumatoid lung; RADP ϭ radiation pneumonia; EP ϭ eosinophilic pneumonia; BAC ϭ bronchioloalveolar carcinoma; ALPR ϭ alveolar proteinosis; TBB ϭ transbronchial biopsy; PB ϭ percutaneous biopsy; OB ϭ open lung biopsy; Gal ϭ gallium scanning; GG ϭ ground-glass opacity; N ϭ nodules; C ϭ consolidation; IT ϭ interstitial thickening; NID ϭ noninflammatory disease.
CT scans were obtained by using 1-to 2-mm collimation scans, high-spatial-frequency reconstruction algorithm, and 10-mm intervals in 16 patients, and by using conventional 4-to 8-mm collimation scans, and 8-mm intervals in 9 patients.
Evaluation of Disease Activity
Evaluation of disease activity was carried out by one or more of the following studies: gallium-radioisotope lung scanning (n ϭ 6), BAL (n ϭ 18), serum angiotensin-converting enzyme (SACE) assay (n ϭ 10), and open lung biopsy (n ϭ 4). These studies were performed within a 1-month period from the time of MRI examinations. Seventeen patients had active disease, and 8 patients had inactive or noninflammatory disease: sarcoidosis (n ϭ 3), UIP (n ϭ 2), rheumatoid lung (n ϭ 1), bronchioloalveolar carcinoma (n ϭ 1), and alveolar proteinosis (n ϭ 1).
Image Analysis
MRI examinations were retrospectively reviewed by two radiologists who had no knowledge of disease activity and reached a decision by consensus. The MRI studies were analyzed for the presence or absence of pulmonary lesion enhancement. The presence of enhancement was considered predictive of active inflammation; the absence of enhancement was considered predictive of inactivity.
Statistical Analysis
Statistical evaluation was performed by using the Fisher Exact Test. A p value Ͻ 0.05 was accepted as indicating a statistically significant difference.
Results
The patients were divided into two groups (Table  1) . Group 1 consisted of 14 patients in whom pulmonary lesion enhancement was present (positive enhancement). Two types of enhancement were observed: (1) enhancement of lesions that were not visible on unenhanced MRI (nine patients; Fig 1, top, middle, and bottom); and (2) enhancement of lesions that were visible also on unenhanced MRI (five patients; Fig 2, top, middle, and bottom) . Group 2 consisted of 11 patients in whom no enhancement of the pulmonary lesions was present (negative enhancement) (Fig 3, top and bottom) . All group 1 patients had active disease. In group 2, eight patients had inactive or noninflammatory disease, and three patients had active disease (two patients with sarcoidosis, and one patient with DIP). The positive enhancement was seen in 14 of 17 patients (82%) with active disease, and in none of 8 patients with inactive disease. The difference is statistically significant. Negative enhancement was seen in 8 of 8 patients (100%) with inactive disease, and in 3 of 17 patients (18%) with active disease. The difference is statistically significant.
Discussion
Despite the wide range of origins of CILD, the sequence of pathologic changes that lead to chronic fibrotic interstitial lung disease can be grouped broadly into three phases. 4 The first stage of injury is an early exudative phase, with an accumulation of inflammatory cells in the alveolar septa and airspaces. This phase results, in part, from injury to the capillary endothelium. The second phase is an intermediate organizing phase with collagen derangement. The third phase culminates in severe fibrosis of the interstitium. Since the best response to corticosteroid treatment and the best long-term survival rates are found in patients with marked disease activity and little fibrosis, 5, 6 several modalities have been used to evaluate the relative extent of inflammation and fibrosis, including open lung biopsy, BAL, gallium-radioisotope lung scanning, and HRCT; however, they are often invasive, insensitive, or imprecise. For instance, Leung et al 2 correlated parenchymal opacification on thin-section CT scans with histologic findings in 29 patients with CILD, and concluded that "the presence of parenchymal opacification often, but not always, indicates potentially treatable disease."
Unenhanced T1-and T2-weighted MRI studies have been used in the evaluation of CILD, 17,18 but Muller et al 17 concluded that MRI, when compared with HRCT, is consistently inferior in the assessment Middle: T1-weighted MRI study shows the pulmonary consolidation as a hyperintense area (1), but fails to reveal the groundglass opacity. Bottom: gadolinium-enhanced T1-weighted MRI study demonstrates enhancement of both the pulmonary consolidation (1) and the alveolitis (arrow). of CILD, although it may play a role in the follow-up of patients with airspace opacification.
Berthezène et al 19 investigated the ability of contrast-enhanced MRI to allow differentiation of pulmonary fibrosis and alveolitis in 15 rats with lung damage induced by means of intrabronchial cadmium chloride instillation. They concluded that gadolinium can be useful in differentiating between the exudative and fibrotic phases of diffuse interstitial lung disease. However, to our knowledge, there are no previous reports assessing the value of gadolinium-enhanced T1-weighted MRI studies in the clinical setting of human CILD.
Our data show that the presence of enhancing lesions on gadolinium-enhanced T1-weighted MRI studies may be a reliable indicator of inflammation and, consequently, indicates potentially treatable disease. Pulmonary insults inducing CILD disrupt capillary endothelium and permit the passage of gadolinium from the plasma into the extravascular compartment. Consequently, enhancement of the injured lung parenchyma occurs. However, in three of our patients with active disease, MRI failed to reveal enhancement of the pulmonary lesions. We have seen two types of active nonenhancing lesions: (1) mild alveolitis appearing on HRCT as a mild ground-glass opacity, and (2) small inflammatory nodules surrounded by normal pulmonary parenchyma (Fig 1, bottom) . Two causes can explain the lack of enhancement of these lesions: first, the mild damage of the capillary endothelium in mild alveolitis does not permit the fast passage of gadolinium into the extravascular space in the first minutes after infusion of the contrast agent. The use of a more delayed imaging should be investigated in these patients. Second, the air into the normal parenchyma surrounding small inflammatory nodules disrupts the magnetic resonance signal of intralesional gadolinium. Since we used 5-mm-thick MRI sections, it is not improbable that thinner MRI sections could improve the ability to visualize this type of lesions.
Conclusion
Our study had the following limitations: (1) the small number of patients included, (2) the heterogeneity of diseases investigated, (3) the lack of follow-up studies to assess the value of gadoliniumenhanced MRI in the therapeutic management of patients with CILD, and (4) the lack of a reliable "gold standard" for disease activity. The presence of gadolinium enhancement has not been directly compared with histologic presence of inflammation. Ideal pathologic correlation with MRI findings would require open lung biopsy after every MRI study. Despite these limitations, we think that gadolinium-enhanced MRI may prove to be a valuable tool in the evaluation of disease activity in CILD. Although the cost of gadolinium-enhanced MRI is a major limitation, this cost is less than that of invasive procedures, such as open lung biopsy, currently used to diagnose disease activity. In addition, an important advantage of MRI over CT is the lack of ionizing radiation. Further studies should be performed to assess the value of gadolinium-enhancement in CILD.
